2023

Colville A, Liu JY, Rodriguez-Mateo C, Thomas S, Ishak HD, Zhou R, Klein JDD, Morgens DW, Goshayeshi A, Salvi JS, Yao D, Spees K, Dixon SJ, Liu C, Rhee JW, Lai C, Wu JC, Bassik MC, Rando TA. Death-seq identifies regulators of cell death and senolytic therapies. Cell Metabolism. 2023 Sep 5:S1550-4131(23)00303-0. doi: 10.1016/j.cmet.2023.08.008.

Liu C# *, Shen M#, Tan WLW#, Chen IY, Liu Y, Yu X, Yang H, Zhang A, Liu Y, Zhao MT, Ameen M, Zhang M, Gross ER, Qi LS, Sayed N*, Wu JC*. Statins improve endothelial function via suppression of epigenetic-driven EndMT. Nature Cardiovascular Research. 2023 May;2(5):467-485. doi: 10.1038/s44161-023-00267-1. (# first-author, * corresponding-author)

Shen M#, Liu C#, Zhao SR, Manhas A, Sundaram L, Ameen M, Wu JC*. Stepwise Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pericytes to Model Coronary Microvascular Dysfunction. Circulation. 2023 Feb 7;147(6):515-518. doi: 10.1161/CIRCULATIONAHA.122.061770. (# first-author, * corresponding-author)

Liu C# *, Shen, M.#, Liu, Y.X., Nishiga, M., Thomas, D., Rhee, J., Sayed, N., Qi, S., and Wu, J.C. Identify Druggable Genes Responsible to Doxorubicin-induced Cardiotoxicity (DIC) using CRISPR i/a screen. Cell Stem Cell (In resubmission, # first-author, * corresponding-author)

2022

Yang Y, Liu A, Tsai CT, Liu C, Wu JC, Cui B. Cardiotoxicity drug screening based on whole-panel intracellular recording. Biosensors and Bioelectronics. 2022 Nov 15;216:114617. doi: 10.1016/j.bios.2022.114617.

Wang J, Soto F, Ma P, Ahmed R, Yang H, Chen S, Wang J, Liu C, Akin D, Fu K, Cao X, Chen P, Hsu EC, Soh HT, Stoyanova T, Wu JC, Demirci U. Acoustic Fabrication of Living Cardiomyocyte-based Hybrid Biorobots. ACS Nano. 2022 Jul 26;16(7):10219-10230.

Wei TT, Chandy M, Nishiga M, Zhang A, Kumar KK, Thomas D, Manhas A, Rhee S, Justesen JM, Chen IY, Wo HT, Khanamiri S, Yang JY, Seidl FJ, Burns NZ, Liu C, Sayed N, Shie JJ, Yeh CF, Yang KC, Lau E, Lynch KL, Rivas M, Kobilka BK, Wu JC. Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation. Cell. 2022 May 12;185(10):1676-1693.e23. doi: 10.1016/j.cell.2022.04.005.

Nishiga M, Liu C, Qi L.S, Wu JC. The use of new CRISPR tools in cardiovascular research and medicine. Nature Review Cardiology. 2022 Feb 10. 505_521.

2021

Zhang M, Qian L, Liu C, Huang GN, Tao G. Editorial: Cardiomyocyte Maturation: Novel Insights for Regenerative Medicine. Frontiers in Cell and Developmental Biology. 2021 Aug 2;9:730622. doi: 10.3389/fcell.2021.730622.

Liu C#, Ameen M, Himmati S, Thomas D, Sayed N*. Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling. Methods in Molecular Biology. 2021;2239:153-162. doi: 10.1007/978-1-0716-1084-8_10. (# first-author, * corresponding-author)

Paik DT, Tian L, Williams IM, Rhee S, Zhang H, Liu C, Mishra R, Wu SM, Red-Horse K, Wu JC. Single-Cell RNA Sequencing Unveils Unique Transcriptomic Signatures of Organ-Specific Endothelial Cells. Circulation. 2020 Nov 10;142(19):1848-1862.

2020

Sayed N#, Liu C#, Ameen M, Himmati F, Zhang JZ, Khanamiri S, Moonen JR, Wnorowski A, Cheng L, Rhee JW, Gaddam S, Wang KC, Sallam K, Boyd JH, Woo YJ, Rabinovitch M, Wu JC*. Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy. Science Translational Medicine. 2020 Jul 29;12(554):eaax9276. doi: 10.1126/scitranslmed.aax9276. (# first-author, * corresponding-author)

Liu C#, Ruan H#, Himmati F, Zhao MT, Chen CC, Makar M, Chen IY, Sallam K, Mocarski ES, Sayed D, Sayed N*. HIF1α Regulates Early Metabolic Changes due to Activation of Innate Immunity in Nuclear Reprogramming. Stem Cell Reports. 2020 Feb 11;14(2):192-200. doi: 10.1016/j.stemcr.2020.01.006. (# first-author, * corresponding-author)

Before 2020

Zhang JZ, Termglinchan V, Shao NY, Itzhaki I, Liu C, Ma N, Tian L, Wang VY, Chang ACY, Guo H, Kitani T, Wu H, Lam CK, Kodo K, Sayed N, Blau HM, Wu JC. A Human iPSC Double-Reporter System Enables Purification of Cardiac Lineage Subpopulations with Distinct Function and Drug Response Profiles. Cell Stem Cell. 2019 May 2;24(5):802-811.e5. doi: 10.1016/j.stem.2019.02.015.

Liu C#, Oikonomopoulos A, Sayed N, Wu JC*. Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond. Development. 2018 Mar 8;145(5):dev156166. doi: 10.1242/dev.156166. (# first-author, * corresponding-author)

Sayed N, Liu C, Wu JC. Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. J Am Coll Cardiol. 2016 May 10;67(18):2161-2176. doi: 10.1016/j.jacc.2016.01.083.

Hou P#, Li Y#, Zhang X#, Liu C#, Guan J#, Li H#, Zhao T, Ye J, Yang W, Liu K, Ge J, Xu J, Zhang Q, Zhao Y, Deng H*. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science. 2013 Aug 9;341(6146):651-4. doi: 10.1126/science.1239278. (# first-author, * corresponding-author)